Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01FFX
|
||||
Former ID |
DNC009134
|
||||
Drug Name |
4-((naphthalen-2-yloxy)methyl)piperidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530012] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H19NO
|
||||
Canonical SMILES |
C1CNCCC1COC2=CC3=CC=CC=C3C=C2
|
||||
InChI |
1S/C16H19NO/c1-2-4-15-11-16(6-5-14(15)3-1)18-12-13-7-9-17-10-8-13/h1-6,11,13,17H,7-10,12H2
|
||||
InChIKey |
MUOXAGUZMVATIC-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [530012] | |
Sodium-dependent serotonin transporter | Target Info | Inhibitor | [530012] | ||
5-hydroxytryptamine receptor 3A | Target Info | Inhibitor | [530012] | ||
Sodium-dependent noradrenaline transporter | Target Info | Inhibitor | [530012] | ||
KEGG Pathway | Serotonergic synapsehsa04726:Serotonergic synapse | ||||
NetPath Pathway | TCR Signaling PathwayNetPath_14:IL2 Signaling Pathway | ||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
WikiPathways | SIDS Susceptibility Pathways | ||||
Hematopoietic Stem Cell Differentiation | |||||
Potassium ChannelsWP727:Monoamine Transport | |||||
NRF2 pathway | |||||
Synaptic Vesicle Pathway | |||||
Serotonin Transporter ActivityWP706:SIDS Susceptibility Pathways | |||||
Iron uptake and transportWP727:Monoamine Transport | |||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.